Harbin Medisan Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2020
August 26, 2020 at 04:24 am
Share
Harbin Medisan Pharmaceutical Co., Ltd. announced earnings results for the half year ended June 30, 2020. For the half year, the company announced sales was CNY 627.170 million compared to CNY 1,126.418 million a year ago. Operating income was CNY 37.267 million compared to CNY 146.963 million a year ago. Net income was CNY 28.110 million compared to CNY 116.974 million a year ago. Basic earnings per share from continuing operations was CNY 0.09 compared to CNY 0.37 a year ago.
HARBIN MEDISAN PHARMACEUTICAL CO LTD is a China-based company principally engaged in the research and development, production and sales of chemical preparations, active pharmaceutical ingredients (APIs), medical devices and cosmetics. Its medicines cover the nervous system, cardio-cerebrovascular, systemic anti-infection, musculoskeletal, nutritional infusion, and body fluid balance infusion therapeutic fields. The Company's products include freeze-dried powder injections, small volume injections, large infusion products, solid preparations, medical devices and cosmetics. The Company mainly distributes its products within domestic market.
HARBIN MEDISAN PHARMACEUTICAL CO., LTD. 
